ORGO
Organogenesis Holdings Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$0.87
+4.19%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.49x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.39x
- Price / sales
- 0.25x
- Price / cash flow
- 3.50x
Enterprise value
- Enterprise value
- $272.7M
- EV / sales
- 0.60x
- EV / EBITDA
- -150.73x
- EV / EBIT
- -9.35x
- Market cap
- $111.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026